Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  liposomal amphotericin B
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-8 of 8 for your search:
Start Over
Inhalation of Liposomal Amphotericin B to Prevent Invasive Aspergillosis
Phase: Phase III, Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: METC 191.137/2000/088, NCT00263315
Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2007-0020, NCT00750737
Prevention of Invasive Fungal Infections (IFIs) in Subjects Receiving Chemotherapy for Acute Lymphoblastic Leukemia
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GS-EU-131-0247, 2010-019562-91, NCT01259713
Phase I/II Pilot Study of Amphotericin-B Lipid Complex in the Treatment of Hepatosplenic Candidiasis in Children with Neoplastic Disease
Phase: Phase II, Phase I
Type: Supportive care
Status: Completed
Age: 2 to 18
Sponsor: NCI
Protocol IDs: NCI-92-C-0047B, NCI-T92-0001N, T92-0001
MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients (0991-044)
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 2 to 17
Sponsor: Pharmaceutical / Industry
Protocol IDs: 0991-044, Formerly-0404ETPP, MK0991-044, 2004_101, NCT00082537
Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary Aspergillosis
Phase: Phase II
Type: Supportive care
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: 2005-000703-34, AMBINEB, NCT00391014
Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-0536, NCT00418951
Randomized, Multicenter Study of Liposomal Amphotericin B (1 mg/kg vs 4 mg/kg) in the Treatment of Neutropenic Patients with Invasive Aspergillosis
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: over 1
Sponsor:
Protocol IDs: EORTC-19923
Start Over